- The report shows digital health technologies demonstrate
value, yet integrating them into care systems remains challenging.
Involving healthcare professionals and patients in technology
design and development is also critical for patient-centred
care.1
- The report surveyed 10 countries, all of which have some
foundations in place to use digital health technologies, such as
regulatory frameworks and interoperability standards.
- The report illustrates additional challenges, such as
fragmented national-level electronic health record systems and a
lack of established health technology assessment (HTA) mechanisms
for digital tools in some countries.2
BASEL, Switzerland,
Sept. 5, 2023 /PRNewswire/ -- Roche
(SIX: RO, ROG; OTCQX: RHHBY) – The Economist Impact report,
Advancing the Frontier of Health and Technology Integration: The
2023 Digital Health Barometer, commissioned by Roche
Diagnostics, examines the digital health environment in and across
ten diverse countries from advanced economies to emerging
markets: Australia,
Brazil, France, Germany, Japan, Mexico, South
Korea, Spain, the UK and
the US.
The report reveals that despite continuing challenges to
integrate new technologies into healthcare organisations and
systems, all countries have some foundations in place to use
digital health technologies, such as regulatory frameworks and
interoperability standards. Only half of the countries surveyed had
integrated electronic health records in place at the national
level, which could support healthcare systems in improving patient
care and productivity.3 The report emphasises that
ongoing education and support around digital health topics for
healthcare professionals and patients is essential for building
trust and driving adoption.
"We are confident that these insights will stimulate robust
discussions about how to best integrate innovative digital
technologies into healthcare systems," said Moritz Hartmann, Global Head, Roche Information
Solutions at Roche Diagnostics. "We work with labs and hospitals
around the world to bring them the latest digital health
technologies and we know the importance of inclusive
stakeholder collaboration and designing with healthcare
professionals and patient needs in mind."
The report also included a survey of 1,000 healthcare consumers
across the 10 countries, and highlighted that two thirds indicated
they would be 'somewhat comfortable' or 'very comfortable' about
their health providers using their data for preventive treatment in
the future. Data privacy remains a top concern, especially in
Australia, France, Mexico and Spain where 48%, 45%, 45% and 54%,
respectively, of the surveyed population considered it to be the
most important factor in their decision to use a new health
technology. Respondents in South
Korea and Japan are the
most sceptical about the ability of health technology to safeguard
patient data.
According to the report, the future of digital health technology
relies on collaboration in four areas: 1) equity and fairness, 2)
financing and reimbursement, 3) patient centricity, and 4) adoption
and acceptance. The report emphasised that stakeholder
collaboration across these areas is critical for integrating
digital health technologies into systems successfully.
Roche commissioned the report as part of its ongoing commitment
to bring innovative solutions to health systems that support in the
effort to improve access, experience and delivery of care,
including its navify digital solution portfolio.
About Roche
Founded in 1896 in Basel,
Switzerland, as one of the first industrial manufacturers of
branded medicines, Roche has grown into the world's largest
biotechnology company and the global leader in in-vitro
diagnostics. The company pursues scientific excellence to discover
and develop medicines and diagnostics for improving and saving the
lives of people around the world. We are a pioneer in personalised
healthcare and want to further transform how healthcare is
delivered to have an even greater impact. To provide the best care
for each person we partner with many stakeholders and combine our
strengths in Diagnostics and Pharma with data insights from the
clinical practice.
In recognising our endeavour to pursue a long-term perspective
in all we do, Roche has been named one of the most sustainable
companies in the pharmaceuticals industry by the Dow Jones
Sustainability Indices for the thirteenth consecutive year. This
distinction also reflects our efforts to improve access to
healthcare together with local partners in every country we
work.
Genentech, in the United
States, is a wholly owned member of the Roche Group. Roche
is the majority shareholder in Chugai Pharmaceutical, Japan.
For more information, please visit www.roche.com.
All trademarks used or mentioned in this release are protected
by law.
References
1 Economist Impact: Advancing the Frontier of
Health and Technology Integration: The 2023 Digital Health
Barometer, visit diagnostics.roche.com or Economist
Impact for more information.
2 Countries in the report with a digital mechanism in
the HTA process are Australia,
France, Germany, South
Korea, Spain and the UK.
The countries in the report without: Brazil, Japan, Mexico, and the USA. Countries without integrated
national-level electronic health records in the report include:
Germany, Japan, Mexico, UK and the US.
3 The countries in the report that have integrated
national-level electronic health records (EHRs) include
Australia, Brazil, France, South
Korea and Spain.
For further information please contact:
Roche Group Media
Relations Phone: +41 61 688 8888 / e-mail:
media.relations@roche.com
|
Hans Trees,
PhD
Phone: +41 79 407 72
58
|
Nathalie
Altermatt
Phone: +41 79 771 05
25
|
Karsten
Kleine
Phone: +41 79 461 86
83
|
Nina
Mählitz
Phone: +41 79 327 54
74
|
Kirti
Pandey
Phone: +49 172
6367262
|
Rebekka
Schnell
Phone: +41 79 205 27
03
|
Sileia
Urech
|
|
Phone: +41 79 935 81
48
|
|
Logo -
https://mma.prnewswire.com/media/2169925/Roche_Navify_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/economist-impact-report-advancing-the-frontier-of-health-and-technology-integration-the-2023-digital-health-barometer-highlights-opportunities-in-digitalisation-of-healthcare-301917140.html